Lyell Immunopharma, Inc logo

LYEL

Lyell Immunopharma, Inc

$2.89

Earnings Summary

Revenue
$0.07Mn
Net Profits
$-132.63Mn
Net Profit Margins
-204046.15%

Highlights

Revenue:

Lyell Immunopharma, Inc’s revenue fell -88.25% since last year same period to $0.07Mn in the Q1 2023. On a quarterly growth basis, Lyell Immunopharma, Inc has generated 34.34% jump in its revenue since last 3-months.

Net Profits:

Lyell Immunopharma, Inc’s net profit fell -94.63% since last year same period to $-132.63Mn in the Q1 2023. On a quarterly growth basis, Lyell Immunopharma, Inc has generated -1579392.68% fall in its net profits since last 3-months.

Net Profit Margins:

Lyell Immunopharma, Inc’s net profit margin fell -1555.87% since last year same period to -204046.15% in the Q1 2023. On a quarterly growth basis, Lyell Immunopharma, Inc has generated -1175674.35% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Lyell Immunopharma, Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.27
EPS Estimate Current Year
-0.27

Highlights

EPS Estimate Current Quarter:

Lyell Immunopharma, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.27 - a 13.24% jump from last quarter’s estimates.

EPS Estimate Current Year:

Lyell Immunopharma, Inc’s earning per share (EPS) estimates for the current year stand at -0.27.

Key Ratios

Key ratios of the Lyell Immunopharma, Inc post its Q2 2023 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

Lyell Immunopharma, Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Lyell Immunopharma, Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-08-10
-0.27
0
100%
2023-05-04
-0.32
0
100%